KML29

CAS: 1380424-42-9

Ref. 3D-FFC42442

Produktinformation

• Name: KML29
• CAS: 1380424-42-9

Beschreibung

KML29 is an amide compound that acts as a cannabinoid receptor agonist. It has been shown to be neuroprotective in in vitro experiments with cultured neurons and in vivo studies with rats injected with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) to induce Parkinson's disease. KML29 also inhibits neuronal death induced by the fatty acid, arachidonic acid, and exhibits anti-cancer activity in a mouse model of prostate cancer. KML29 has been shown to have an effective dose at 1 mg/kg for striatal dopamine release and locomotor activity. The drug also binds to the GABAA receptor and shows efficacy against anxiety, depression, and seizures.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 549.42 g/mol
• Formel: C₂₄H₂₁F₆NO₇
• Reinheit: Min. 95%